FMR LLC 13D and 13G filings for Centessa Pharmaceuticals plc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-06 11:06 am Sale | 2026-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 6,783,047 7.500% | -4,216,746 (-38.33%) | Filing |
| 2026-02-06 1:11 pm Purchase | 2026-01-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 10,999,793 12.200% | 2,104,854 (+23.66%) | Filing |
| 2026-02-05 1:20 pm Purchase | 2025-12-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 8,894,939 9.900% | 2,617,696 (+41.70%) | Filing |
| 2025-11-05 11:30 am Purchase | 2025-09-30 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | FMR LLC | 6,277,243 7.000% | 6,277,243 (New Position) | Filing |